ISO/IEC 17025, SWGDAM, ENFSI DNA WG and NABL Accreditation in Operational Labs

The Scientific Working Group for DNA Analysis Methods was established by the FBI Laboratory in the 1980s and functioned as the consensus-building body for the US forensic DNA community until it was formally reorganised as OSAC (Organization of Scientific Area Committees for Forensic Science, under NIST) in 2014. Despite the transition, the SWGDAM legacy documents remain in active use, and new guidance continues to be issued under the SWGDAM name for the FBI Quality Assurance Standards ecosystem.

The most widely cited document is the SWGDAM Interpretation Guidelines for Autosomal STR Typing by Forensic DNA Testing Laboratories (2017). This document defines analytical thresholds (the limit of detection, the stochastic threshold, the interpretation threshold), establishes the protocol for mixture interpretation, and sets the statistical framework for reporting. It distinguishes between random-match probability (RMP) and likelihood-ratio (LR) reporting, and specifies that any statistical conclusion must be accompanied by the underlying allele-frequency database used. For probabilistic genotyping systems, the SWGDAM Validation Guidelines (2015) specify the empirical testing required before a software package like STRmix or TrueAllele can be used in casework.

Proficiency testing is a central SWGDAM requirement. The FBI Quality Assurance Standards require that each analyst performing forensic DNA analysis participate in an external proficiency test at least twice per year. Collaborative Testing Services (CTS) and Forensic Science International provide the most widely used PT schemes in the US. Results of failed proficiency tests must trigger a corrective-action process documented in the quality management system, and a pattern of failures in an external audit can result in suspension of FBI QAS compliance.

In the European Union, the parallel framework is the ENFSI DNA WG Proficiency Test scheme and the ENFSI-coordinated collaborative exercises. National accreditation bodies verify PT participation as part of surveillance audits under ISO/IEC 17025. In Australia, the NATA-accredited Victorian Institute of Forensic Medicine (VIFM) and Queensland Health Forensic and Scientific Services participate in the ENFSI PT programme as well as NATA's own scheme.

The European Network of Forensic Science Institutes was founded in 1993 and now encompasses more than eighty member laboratories across Europe. The DNA Working Group within ENFSI is one of its most active bodies, producing the documents that underpin DNA database operations under the EU Prüm framework and expert-witness reporting in member states.

The ENFSI DNA WG Best Practice Manual for the Forensic Examination of DNA, last comprehensively revised in 2016, covers sample collection, chain of custody, extraction, quantification, PCR amplification, CE separation, profile interpretation, and statistical reporting. It defines the European Standard Set (ESS) of STR loci, which began at seven loci in the EDNAP 1992 minimum, expanded to twelve loci in 1997, to fifteen loci in 2009 (the well-known ESS expansion that added D1S1656, D2S441, D10S1248, D12S391 and D22S1045), and to seventeen loci (ESS17) in 2012; the ESS17 set substantially overlaps the US CODIS core such that the 2017 CODIS 20 expansion preserved cross-Atlantic interoperability. The ESS17 requires that every DNA database profile loaded into a national database that participates in Prüm exchange must include at least the seventeen loci.

The ENFSI Guideline for Evaluative Reporting in Forensic Science (2015) is the document that most directly shapes how a DNA expert witness presents conclusions to a court in Europe. It mandates a likelihood-ratio framework: the expert must define two competing propositions (prosecution's hypothesis and defence's hypothesis), calculate the LR for the biological findings given each proposition, and report the LR with a verbal scale of evidential strength. This framework is now standard in the UK, the Netherlands, Sweden, Germany, and most other EU member states. In cases where the LR exceeds one billion, the evidence is described as "extremely strong support" for the prosecution's hypothesis; below one thousand, as "moderate support". The scale is not legally binding but is reproduced in most national guidelines.

The ENFSI PT scheme sends blind samples to participating laboratories and compares profile outputs. A laboratory that systematically diverges from the consensus result triggers a quality investigation at the national accreditation body. Since 2010, ENFSI has also run collaborative exercises on mixture interpretation and probabilistic genotyping, reflecting the increasing proportion of casework involving complex mixtures.

1. ENFSI DNA WG membership and audit
   A national forensic institute applies for ENFSI membership, undergoes a technical audit against the DNA WG Best Practice Manual, and is accepted if the audit panel confirms minimum technical competence. Continued membership requires participation in the annual PT scheme.
2. Prüm data exchange registration
   For a national database to upload profiles for cross-border automated searching under the Prüm framework (Council Decisions 2008/615/JHA and 2008/616/JHA), the national authority must certify that uploaded profiles meet the ESS17 locus set and that the laboratory producing them is accredited against ISO/IEC 17025.
3. Evaluative reporting in casework
   When a match triggers a criminal investigation, the assigned case examiner writes a report structured per the ENFSI Evaluative Reporting guideline: competing propositions, LR calculation with named allele-frequency database, verbal scale statement, and any caveats about profile quality or mixture complexity.
4. Court appearance and cross-examination
   The expert testifies, refers to the accredited status of the laboratory, identifies the validation study supporting the method, and explains the LR to the court. Defence experts in most EU jurisdictions can request the underlying electropherogram data and validation records under disclosure rules.

The National Accreditation Board for Testing and Calibration Laboratories (NABL) is India's ISO/IEC 17025 accreditation body, operating under the Department for Promotion of Industry and Internal Trade. It is a signatory of the ILAC (International Laboratory Accreditation Cooperation) mutual-recognition arrangement, meaning a NABL certificate is internationally recognised as meeting ISO/IEC 17025 requirements. NABL accreditation for forensic laboratories covers the specific methods listed in the accreditation scope, not the laboratory as a whole: a state FSL accredited for STR profiling may not be accredited for toxicology, and vice versa.

The Central Forensic Science Laboratories (CFSLs) under the Directorate of Forensic Science Services (DFSS) in Hyderabad, Chandigarh, and Kolkata, along with the Central DNA Analysis Centre (C-DAC) in Hyderabad, hold NABL accreditation for DNA analysis. State FSLs vary considerably. Maharashtra's Forensic Science Laboratory in Mumbai, Tamil Nadu's State FSL in Chennai, and the Delhi FSL have pursued and maintained NABL accreditation for DNA profiling. Smaller state FSLs in some north-eastern states and union territories remain outside the accredited network and must refer casework to the CFSLs, which creates backlog pressures that affect case timelines.

Under the DNA Technology (Use and Application) Regulation Bill 2019 (not yet enacted as of 2025), every laboratory proposing to conduct DNA tests for forensic, investigative, or regulatory purposes would be required to be accredited by NABL and listed in a national register maintained by the DNA Regulatory Board. The Bill envisions the Board as the equivalent of the FBI QAS compliance office, with power to inspect, suspend, and decertify laboratories. Until the Bill passes, the quality assurance framework rests on NABL accreditation (which is voluntary in the absence of enabling legislation) and on CFSL internal SOPs.

India's quality challenges are not unique. In the United Kingdom, the closure of the Forensic Science Service in 2012 and the transition to a fragmented private-provider market prompted the establishment of the Forensic Science Regulator, whose Codes of Practice were given statutory backing by the Forensic Science Regulator Act 2021. In the United States, the 2009 National Academy of Sciences report "Strengthening Forensic Science in the United States" identified quality-system weaknesses across multiple forensic disciplines and directly prompted the creation of NIST OSAC. In both cases, the response was more external oversight, more mandatory proficiency testing, and tighter accreditation requirements.

Method validation in a forensic DNA laboratory is a structured empirical exercise, not a literature review. ISO/IEC 17025 requires that laboratories validate non-standard methods, methods developed in-house, standard methods used outside their intended scope, or extensions of standard methods. In practice, when a US laboratory adopts a new commercial STR kit, the SWGDAM Validation Guidelines for DNA Analysis Methods (2016) prescribe the minimum studies: sensitivity (lowest DNA input producing a complete profile above the analytical threshold), mixture studies (two- and three-person mixtures covering contributor ratio ranges likely to be encountered in casework), substrate studies (at least five substrates representative of casework), inhibitor studies, reproducibility (multiple runs, multiple analysts), and concordance (comparison with profiles generated on the outgoing platform). Results are documented in a validation report reviewed by the laboratory director and retained as part of the quality record.

Proficiency testing serves a different function from validation: it is an ongoing check that a validated method remains in control and that individual analysts can apply it correctly. A distinction is made between internal (blind in-house samples) and external (third-party blind samples) proficiency testing. The FBI QAS requires external PT at minimum twice per year per analyst. ENFSI's PT scheme tests whole-laboratory performance. NABL surveillance audits require documentation of PT participation and results. When a laboratory fails a PT, the corrective-action record must demonstrate root-cause analysis: was it a sample preparation error, an instrument drift, a software interpretation issue, or an analyst training gap?

The concept of measurement uncertainty, central to ISO/IEC 17025, is sometimes treated as abstract by biological laboratories more accustomed to qualitative results. For quantitative outputs like likelihood ratios, however, a credible measurement-uncertainty estimate is increasingly expected. The ENFSI Evaluative Reporting Guideline and the SWGDAM guidelines both address the requirement to characterise uncertainty in LR calculations, including sensitivity analysis that varies the allele-frequency database.

The audit trail in an accredited forensic DNA laboratory begins the moment a biological exhibit is received and does not end until the expert-witness statement is filed with the court, or in some jurisdictions, until the analyst leaves the witness box. ISO/IEC 17025 Clause 7.4 requires that all sample handling be documented: the condition of the item on receipt, any sub-sampling, storage location and conditions, and the identity of every person who accessed the item. In US federal cases governed by the Federal Rules of Evidence, and in UK Crown Court proceedings under the Criminal Procedure Rules, the defence has the right to request the full case file, including all bench notes, instrument output files, and corrective-action records. A gap in the audit trail, particularly between sample receipt and the first analytical step, is a known attack vector in cross-examination.

In a well-run laboratory, each case file will contain: a case-initiation record with a unique case reference number; a chain-of-custody log listing every analyst who handled each exhibit; instrument calibration and maintenance logs confirming that every piece of equipment used was in calibration at the time of analysis; electropherogram files (raw data in the platform's proprietary format plus exported results); the interpretation worksheet documenting threshold decisions and allele calls; the statistical calculation output (RMP or LR) with the named allele-frequency database and version; the technical review sign-off confirming a second analyst independently verified the interpretation; the administrative review sign-off confirming the report is complete and the case file is consistent; and the final expert-witness statement or report.

ISO 21043:2018 (Forensic sciences, Parts 1 and 2) provides an overarching international framework for the forensic science process, complementing ISO/IEC 17025. Part 2 (Part 1 covers terms and definitions) covers the recognition, recording, collection, transportation, storage, examination, interpretation, reporting, and review of examination results. While ISO 21043 is not yet as widely incorporated into national accreditation schemes as ISO/IEC 17025, ENFSI and the UK FSR both reference it in their documentation.

In Indian courts, the admissibility of forensic evidence is governed by the Bharatiya Sakshya Adhiniyam 2023, which inherited the Indian Evidence Act's evidentiary framework. Expert opinion is admissible under BSA § 39 (formerly IEA § 45), and chain-of-custody documentation supports the authentication of physical evidence. In a series of cases before Indian High Courts and the Supreme Court, gaps in chain-of-custody documentation have been grounds for questioning forensic evidence weight, even where the underlying analytical result was not disputed. The Bombay High Court in State v. Suresh Nivrutti Bhoir (2011) noted the absence of a signed transfer record from scene to laboratory as a factor reducing evidentiary weight.